ArticleCancer medicine2019

Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.